Representative before the EPO

Employment test 11 - 50 employees
Company dna kraus and weisert patentanwalte partgmbb
operating since 1974
Headquarter in Munich
active in Legal Services and IP Consulting

Representative before the EPO

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

Oliver Ladendorf has worked on the following 44 EPO patent applications which have been published in the last five years:

EP13172175

Beverage compositions

IPC classification:
A23F 3/14
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13738479

MAGNETIC NANOPARTICLE-SAMIRNA COMPLEX AND METHOD FOR PREPARING SAME

IPC classification:
A61K 9/16, A61K 31/7088, A61K 31/7105, A61K 47/48
Applicant:
Bioneer Corporation
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13743292

INNERVATION OF ENGINEERED STRUCTURES

IPC classification:
A61F 2/08, A61L 27/38, C12N 5/07
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP12852618

CULTURE-MEDIUM COMPOSITION FOR REJUVENATING STEM CELLS

IPC classification:
C12N 1/38, C12N 5/02, C12N 5/0775
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13747196

TREATING WASTE STREAMS WITH ORGANIC CONTENT

IPC classification:
C02F 1/52
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13768152

METHODS FOR TREATING NEOPLASIA

IPC classification:
A61K 31/337, A61K 38/17, A61K 38/20, A61P 35/00
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13775784

METHOD AND COMPOSITION FOR PREVENTING STEM CELL DISRUPTION AND AGGREGATION

IPC classification:
A61K 35/12, C12N 5/074, C12N 5/0775
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13794539

RNA-INTERFERENCE-INDUCING NUCLEIC ACID MOLECULE ABLE TO PENETRATE INTO CELLS, AND USE THEREFOR

IPC classification:
A61K 48/00, C12N 15/113, C12N 15/63
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13793331

NUCLEIC ACID AMPLIFICATION AND USE THEREOF

IPC classification:
C12N 15/11, C12Q 1/68
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13786285

MEANS AND METHODS FOR IDENTIFYING RIBOSOME ASSOCIATED RNA MOLECULES

IPC classification:
C12Q 1/68
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13857338

DUAL-TARGET ANTIBODY TARGETING VEGFR-2 AND DLL4, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

IPC classification:
A61K 39/395, C07K 16/46, C07K 19/00, C12N 15/62
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13812385

USE OF PROBES FOR MASS SPECTROMETRIC IDENTIFICATION OF MICROORGANISMS OR CELLS AND ASSOCIATED CONDITIONS OF INTEREST

IPC classification:
C12Q 1/68
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13814963

STABLE TRANSFORMATION OF A POPULATION AND A METHOD OF BIOCONTAINMENT USING HAPLOINSUFFICIENCY AND UNDERDOMINANCE PRINCIPLES

IPC classification:
A01H 1/00, A01K 67/033
Applicant:
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP14708425

TUBERCULOSIS BIOMARKERS AND USES THEREOF

IPC classification:
G01N 33/50, G01N 33/569, G01N 33/68
Applicant:
Albert Einstein College of Medicine Inc.
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14792262

MONOCLONAL ANTIBODY RECOGNIZING SIALYLATED SUGAR CHAINS

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18, C12N 5/10, C12P 21/08, G01N 33/53, G01N 33/574, G01N 33/577
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14791926

IMMUNITY INDUCER FOR SACCHARIDE ANTIGENS

IPC classification:
A61K 31/702, A61K 39/00, A61P 37/04, C07H 15/02, C07K 16/00, C08B 37/00
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14797400

PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS, AND METHODS FOR THE TREATMENT OF ACHROMATOPSIA AND OTHER DISEASES

IPC classification:
A61K 48/00
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14773781

PHOTORESPONSIVE NUCLEOTIDE ANALOGUE HAVING PHOTOCROSSLINKING ABILITY

IPC classification:
C07D 209/86, C07H 19/06, C08F 230/02
Applicant:
Japan Science and Technology Agency
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14807026

MALARIA VACCINE

IPC classification:
A61K 39/015, C07K 14/18, C07K 14/445, C07K 19/00, C12N 7/00, C12N 15/09
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14823421

METHOD FOR DIAGNOSIS OF DISEASES USING MORPHOLOGICAL CHARACTERISTICS OF LUTERIAL

IPC classification:
G01N 33/48, G01N 33/53, G01N 33/58
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14823398

VIRUS LIKE PARTICLE COMPRISING PD-1 ANTIGEN OR PD-1 LIGAND ANTIGEN

IPC classification:
C12N 7/00
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14780963

MULTIFUNCTIONAL RNA NANOPARTICLES AND METHODS OF USE

IPC classification:
A61K 47/48, C12N 15/11, C12N 15/87
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14853355

ALPHA HELIX CELL-PENETRATING PEPTIDE MULTIMER, PREPARATION METHOD THEREFOR AND USE THEREOF

IPC classification:
A61K 47/42, C07K 7/02
Applicant:
Seoul National University Research & Development Business Foundation
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14858942

METHOD OF SUPPRESSING FORMATION OF PHOTOCROSSLINK, AND PHOTOREACTIVE NUCLEIC ACID IN WHICH AUTO-CROSSLINK FORMATION IS SUPPRESSED

IPC classification:
C07H 19/073, C07H 21/04, C12N 15/09
Applicant:
Japan Science and Technology Agency
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP13178086

Method for diagnosing acute renal failure or chronic renal failure

IPC classification:
A01N 1/02, A61K 38/17
Applicant:
Children's Medical Center Corporation
Agent:
Oliver Ladendorf, Maiwald Patentanwalts GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14878548

LUTERIAL AND METHOD FOR ISOLATING AND CULTURING SAME

IPC classification:
C12N 1/00, C12Q 1/24
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15737047

METHOD FOR SCREENING CANCER PREVENTION AGENT OR ANTICANCER AGENT USING MORPHOLOGICAL CHARACTERISTICS OF LUTERIAL

IPC classification:
G01N 33/48, G01N 33/53, G01N 33/574
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP16736753

ANTICANCER FUNCTIONAL PEPTIDE FOR INHIBITING PROLIFERATION OF CANCER STEM CELL, AND USE THEREOF

IPC classification:
A61K 9/00, A61K 38/10, A61K 47/30
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15765147

METHODS FOR PREPARATION OF A TERMINALLY STERILIZED HYDROGEL DERIVED FROM EXTRACELLULAR MATRIX

IPC classification:
A61L 27/36, A61L 27/52
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14887849

MELTING CURVE ANALYSIS USING PNA PROBE, METHOD AND KIT FOR ANALYZING NUCLEOTIDE POLYMORPHISM USING MELTING CURVE ANALYSIS

IPC classification:
C12Q 1/68
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15779735

CODON OPTIMIZED NUCLEIC ACID ENCODING A RETINITIS PIGMENTOSA GTPASE REGULATOR (RPGR)

IPC classification:
C12N 9/00, C12N 15/00, C12N 15/64, C12P 21/06
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15783019

PROPHYLACTIC VACCINE AGAINST EGG DROP SYNDROME (EDS)

IPC classification:
A61K 39/235, A61P 15/00, A61P 15/08, A61P 31/12, A61P 31/20, C07K 14/00, C07K 14/075, C07K 16/08, C07K 16/18, C07K 19/00, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, G01N 33/53
Applicant:
The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15825418

METHOD FOR POSITIONING, IN CYTOPLASM, ANTIBODY HAVING COMPLETE IMMUNOGLOBULIN FORM BY PENETRATING ANTIBODY THROUGH CELL MEMBRANE, AND USE FOR SAME

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/32, C07K 16/46, A61K 47/50
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15825508

METHOD FOR SUPPRESSING RAS ACTIVATED IN CELL BY USING ANTIBODY HAVING CYTOPLASM PENETRATION CAPACITY AND COMPLETE IMMUNOGLOBULIN FORM, AND USE FOR SAME

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/32, C07K 16/46, C12N 15/13, G01N 33/53, A61K 47/50
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15829311

VIRUS LIKE PARTICLE COMPRISING MODIFIED ENVELOPE PROTEIN E3

IPC classification:
A61K 39/12, A61P 31/00, A61P 35/00, A61P 37/02, C12N 5/10, C12N 7/00, C12N 15/09
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15818206

COMPOSITION FOR PROMOTING STORAGE STABILITY OF STEM CELLS

IPC classification:
A01N 1/02
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP16195913

SV82 POLYPEPTIDE, AND COSMETIC COMPOSITION FOR REDUCING SKIN WRINKLES AND MAINTAINING SKIN ELASTICITY COMPRISING SV82 POLYPEPTIDE AS ACTIVE INGREDIENT

IPC classification:
A61K 8/64, A61Q 19/08
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15840429

FLAVIVIRUS VIRUS LIKE PARTICLE

IPC classification:
C07K 19/00, C12N 15/09
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
Request for examination was made
EP15900639

CHIMERIC ANTIGEN RECEPTOR CONTAINING INTRACELLULAR DOMAIN OF TOLL-LIKE RECEPTOR

IPC classification:
A61P 35/00, C07K 14/705, C07K 16/30, C07K 19/00, C12N 15/62, C12N 15/63
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
Request for examination was made
EP15854205

RHEUMATOID ARTHRITIS MARKER

IPC classification:
C07K 14/42, C12N 9/64, G01N 33/53, G01N 33/564, G01N 33/573
Applicant:
National Institute of Advanced Industrial Science and Technology
Applicant:
Keio University
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
Request for examination was made
EP17722365

CO HYDRATASE AND METHOD FOR PREPARING FORMIC ACID BY USING SAME

IPC classification:
C12N 9/02, C12P 7/40
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
Request for examination was made
EP15874229

DEVICES, SYSTEMS AND METHODS FOR TREATING UROLOGICAL AND GASTROINTESTINAL DISORDERS BY ELECTRICAL STIMULATION OF THE FOOT

IPC classification:
A61K 31/137, A61K 31/428, A61K 31/435, A61N 1/04, A61N 1/08, A61N 1/18, A61N 1/24, A61N 1/32, A61N 1/372
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
Request for examination was made
EP16735151

METHOD FOR INHIBITING TELOMERASE IN CANCER CELLS BY MEANS OF LUTERION

IPC classification:
A61K 36/22, A61K 48/00
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
Request for examination was made
EP16735173

LUTERION AND SEPARATING AND CULTURING METHODS FOR SAME

IPC classification:
B03C 1/32, B04B 5/00, C12N 5/04, C12N 15/10, C12N 15/113, G01N 33/02, G01N 35/00
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
Request for examination was made

Please Sign in to use this feature